Health Outcomes for Clients of Needle and Syringe Programs in Prisons

dc.contributor.authorLazarus, Jeffrey V.
dc.contributor.authorSafreed-Harmon, Kelly
dc.contributor.authorHetherington, Kristina L.
dc.contributor.authorBromberg, Daniel J.
dc.contributor.authorOcampo, Denise
dc.contributor.authorGraf, Niels
dc.contributor.authorDichtl, Anna
dc.contributor.authorStöver, Heino
dc.contributor.authorWolff, Hans
dc.date.accessioned2019-06-12T08:08:01Z
dc.date.available2019-06-12T08:08:01Z
dc.date.issued2018-04-12
dc.date.updated2019-05-27T09:01:31Z
dc.description.abstractHigh levels of drug dependence have been observed in the prison population globally, and the sharing of injecting drug equipment in prisons has contributed to higher prevalence of bloodborne diseases in prisoners than in the general population. Few prison needle and syringe programs (PNSPs) exist. We conducted a systematic review to assess evidence regarding health outcomes of PNSPs. We searched peer-reviewed databases for data relating to needle and syringe programs in prisons. The search methodology was conducted in accordance with accepted guidelines. Five studies met review inclusion criteria, and all presented evidence associating PNSPs with one or more health benefits, but the strength of the evidence was low. The outcomes for which the studies collectively demonstrated the strongest evidence were prevention of human immunodeficiency virus and viral hepatitis. Few negative consequences from PNSPs were observed, consistent with previous evidence assessments. More research is needed on PNSP effectiveness, and innovative study designs are needed to overcome methodological limitations of previous research. Until stronger evidence becomes available, policymakers are urged to recognize that not implementing PNSPs has the potential to cause considerable harm, in light of what is currently known about the risks and benefits of needle and syringe programs and PNSPs and about the high prevalence of human immunodeficiency virus and viral hepatitis in prisons.
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn0193-936X
dc.identifier.urihttps://hdl.handle.net/2445/134928
dc.language.isoeng
dc.publisherOxford University Press
dc.relation.isformatofVersió postprint del document publicat a: http://dx.doi.org/10.1093/epirev/mxx019
dc.relation.ispartofEpidemiologic Reviews, 2018, vol. 40, num. 1, p. 96-104
dc.relation.urihttp://dx.doi.org/10.1093/epirev/mxx019
dc.rights(c) Lazarus et al., 2018
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (ISGlobal)
dc.subject.classificationDrogoaddicció
dc.subject.classificationPresons
dc.subject.otherDrug addiction
dc.subject.otherPrisons
dc.titleHealth Outcomes for Clients of Needle and Syringe Programs in Prisons
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
Lazarus_et_al_EpiRev_proofs_trackec_changes-27March2018.pdf
Mida:
565.16 KB
Format:
Adobe Portable Document Format